CHCT Community Healthcare Trust Inc
Real Estate Investment Trusts · NYSE · SEC CIK 1631569 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
Margins
Returns
Leverage & solvency
Cash quality & payout
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | 2026Q32026-09-30 | 2026Q22026-06-30 | 2026Q12026-03-31 | 2025Q4*2025-12-31 | 2025Q32025-09-30 | 2025Q22025-06-30 | 2025Q12025-03-31 | 2024Q4*2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | $32.44M | $31.22M | $31.52M | $30.95M | $31.09M | $29.09M | $30.08M | $29.30M |
| SG&A expense | $4.19M | $4.89M | $5.11M | $4.78M | $4.66M | $10.56M | $5.10M | $4.81M |
| Interest expense | $7.51M | $7.43M | $6.80M | $6.96M | $7.08M | $6.59M | $6.35M | $6.41M |
| Net income | $3.07M | $2.36M | $2.55M | $14.43M | $1.64M | -$12.56M | $1.59M | $1.83M |
| EPS (basic) | 0.09 | 0.06 | 0.07 | — | 0.03 | -0.50 | 0.03 | — |
| EPS (diluted) | 0.09 | 0.06 | 0.07 | — | 0.03 | -0.50 | 0.03 | — |
| Dividends declared per share | 0.33 | 0.48 | 0.48 | 0.47 | 0.47 | 0.47 | 0.47 | 0.47 |
| Weighted avg. shares (diluted) | 27.07M | 27.02M | 26.99M | — | 26.93M | 26.80M | 26.73M | — |
| Banking | ||||||||
| Net interest income | $250,000 | $253,000 | $255,000 | $267,000 | $272,000 | -$1.04M | $348,000 | $315,000 |
| Balance sheet | ||||||||
| Cash & equivalents | $1.35M | $2.67M | $2.62M | $3.34M | $3.38M | $4.86M | $2.27M | $4.38M |
| Total assets | $1.00B | $1.00B | $1.01B | $990.76M | $987.26M | $966.29M | $985.11M | $992.56M |
| Long-term debt | $558.38M | $559.32M | $559.26M | $532.20M | $530.14M | $500.08M | $496.02M | $485.95M |
| Total debt | $558.38M | $559.32M | $559.26M | $532.20M | $530.14M | $500.08M | $496.02M | $485.95M |
| Total liabilities | $586.97M | $589.35M | $588.75M | $561.37M | $560.44M | $528.47M | $523.79M | $516.60M |
| Shareholders' equity | $413.44M | $414.24M | $421.34M | $429.39M | $426.82M | $437.82M | $461.32M | $475.96M |
| Net debt | $557.03M | $556.65M | $556.64M | $528.86M | $526.75M | $495.21M | $493.75M | $481.57M |
| Shares outstanding | 28.74M | 28.66M | 28.57M | 28.47M | 28.47M | 28.37M | 28.34M | 28.24M |
| Cash flow statement | ||||||||
| Operating cash flow | $13.87M | $17.53M | $13.74M | $15.50M | $12.72M | $13.80M | $14.41M | $15.66M |
| Capital expenditure | $4.72M | $4.19M | $4.97M | $6.54M | $5.08M | $4.23M | $4.68M | $5.16M |
| Free cash flow | $9.15M | $13.35M | $8.77M | $8.96M | $7.65M | $9.57M | $9.73M | $10.50M |
| Investing cash flow | -$4.50M | -$3.62M | -$27.47M | -$4.00M | -$30.67M | -$441,000 | -$12.59M | -$9.49M |
| Financing cash flow | -$10.70M | -$13.85M | $13.00M | -$11.55M | $16.47M | -$10.77M | -$3.93M | -$4.63M |
| Depreciation & amortization | — | — | $10.66M | $10.81M | $10.90M | $10.88M | $10.94M | $10.80M |
| Stock-based compensation | $1.90M | $2.80M | $2.71M | $2.60M | $2.50M | $7.10M | $2.71M | $2.60M |
| Dividends paid | $9.50M | $13.75M | $13.67M | $13.55M | $13.48M | $13.39M | $13.26M | $13.14M |
Free plan shows the latest 8 periods; Pro shows all 50 🔒
· Financial companies (banks, insurers, …) usually do not report gross profit or operating income; bank revenue is net revenue (net interest income + noninterest income), smaller than "gross interest income + noninterest income".
· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.